ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burdon, J
Right arrow Articles by Kester, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burdon, J
Right arrow Articles by Kester, R.
Eur Respir J 1998; 12: 212-216
Copyright © ERS Journals Ltd 1998


Original Articles

Five years' experience of PAS Port intravenous access system in adult cystic fibrosis

J Burdon, SP Conway, P Murchan, M Lansdown, and RC Kester

An implantable venous access system provides a reliable and painless entry site for intravenous treatment. This study reports the authors' experience with such a system in adult patients with cystic fibrosis. Sixty five (87%) of 75 PAS Ports were placed successfully in 57 patients with cystic fibrosis. Because of early difficulties in advancing the catheter in patients whose veins had been traumatized by repeated courses of intravenous antibiotics, a technique was developed whereby venous entry was gained by direct subclavian puncture. This catheter insertion method was used in 53 (82%) attempts and the catheter was then passed by subcutaneous tunnelling to the port site on the ventral aspect of the upper arm. Fifty seven (88%) insertions were successful under local anaesthetic. The major early and late complications were iatrogenic pneumothorax (six cases) and infection (five cases), respectively. Late complications were more common when there was coexisting disease, e.g. diabetes mellitus, or an acute severe respiratory exacerbation, or when the Port was used for parenteral feeding. In conclusion, the PAS Port can be inserted safely by direct subclavian puncture. It was well tolerated and universally liked by the patients.


This article has been cited by other articles:


Home page
British Journal of Infection ControlHome page
L. J Kelly
The family of vascular access devices
Journal of Infection Prevention, September 1, 2009; 10(1_suppl): s7 - s12.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
A. Ali, H. Zayed, J. Wilkins, H. Wyatt, and H. Rashid
Endovascular Port-a-cath Insertion in a Patient With Cystic Fibrosis and Occluded Superior Vena Cava
Vascular and Endovascular Surgery, June 1, 2009; 43(3): 280 - 283.
[Abstract] [PDF]


Home page
Eur Respir JHome page
A. Munck, S. Malbezin, J. Bloch, M. Gerardin, M. Lebourgeois, J. Derelle, F. Bremont, I. Sermet, M-R. Munck, and J. Navarro
Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients
Eur. Respir. J., March 1, 2004; 23(3): 430 - 434.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. L. Aitken and M. R. Tonelli
Complications of Indwelling Catheters in Cystic Fibrosis : A 10-Year Review
Chest, December 1, 2000; 118(6): 1598 - 1602.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.